Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease

Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant neoplasms, further subcategorized in over 20 histological subtypes. For the most part, treatment for advanced disease is guided by morphology. SGC in general respond poorly to standard chemotherapy, with short durabi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Oncol
Huvudupphovsmän: Di Villeneuve, Larissa, Souza, Ive Lima, Tolentino, Fernanda Davila Sampaio, Ferrarotto, Renata, Schvartsman, Gustavo
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2020
Ämnen:
Oncology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649804/
https://ncbi.nlm.nih.gov/pubmed/33194707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.580141
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk